{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:36:06Z","timestamp":1780623366069,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232283"],"award-info":[{"award-number":["7232283"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117291","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:43:24Z","timestamp":1756482204000},"page":"117291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS\/MAPK inhibition"],"prefix":"10.1016","volume":"242","author":[{"given":"Cen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0096-9033","authenticated-orcid":false,"given":"Yonggang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2025.117291_b0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated Projection of US Cancer Incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bcp.2025.117291_b0010","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians. 2019;69(1):7-34.","DOI":"10.3322\/caac.21551"},{"issue":"43","key":"10.1016\/j.bcp.2025.117291_b0015","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117291_b0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"7592","key":"10.1016\/j.bcp.2025.117291_b0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2025.117291_b0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","article-title":"Expanding the Reach of Precision Oncology by Drugging all KRAS Mutants","volume":"12","author":"Hofmann","year":"2022","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.bcp.2025.117291_b0035","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS(G12D) Inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2025.117291_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.07.002","article-title":"KRAS(G12D) inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8(+) Tcells","volume":"41","author":"Mahadevan","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bcp.2025.117291_b0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer","volume":"32","author":"Stickler","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bcp.2025.117291_b0050","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","author":"Dilly","year":"2024","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bcp.2025.117291_b0055","first-page":"2612","article-title":"Harmine suppresses breast cancer cell migration and invasion by regulating TAZ-mediated epithelial-mesenchymal transition","volume":"12","author":"He","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117291_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.980704","article-title":"The \u03b2-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation","volume":"13","author":"Noman","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117291_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119112","article-title":"Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK\/AKT pathway","volume":"270","author":"Zhu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2025.117291_b0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncomms1090","article-title":"Development of a novel selective inhibitor of the down syndrome-related kinase Dyrk1A","volume":"1","author":"Ogawa","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117291_b0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pestbp.2019.01.002","article-title":"Harmine induced apoptosis in Spodoptera frugiperda Sf9 cells by activating the endogenous apoptotic pathways and inhibiting DNA topoisomerase I activity","volume":"155","author":"Shu","year":"2019","journal-title":"Pestic. Biochem. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.06.010","article-title":"Single-Cell RNA-Sequencing reveals Lineage-specific Regulatory changes of Fibroblasts and Vascular Endothelial Cells in Keloids","volume":"142","author":"Liu","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117291_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054399","article-title":"Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease","volume":"24","author":"Vrabec","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117291_b0090","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.2147\/OTT.S205097","article-title":"Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment","volume":"12","author":"Wu","year":"2019","journal-title":"OncoTargets and Therapy."},{"key":"10.1016\/j.bcp.2025.117291_b0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12935-019-0880-4","article-title":"Harmine suppresses hyper-activated Ras-MAPK pathway by selectively targeting oncogenic mutated Ras\/Raf in Caenorhabditis elegans","volume":"19","author":"Ji","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.bcp.2025.117291_b0100","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1248\/bpb.34.1264","article-title":"The \u03b2-carboline alkaloid harmol induces cell death via autophagy but not apoptosis in human non-small cell lung cancer A549 cells","volume":"34","author":"Abe","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"44","key":"10.1016\/j.bcp.2025.117291_b0105","doi-asserted-by":"crossref","first-page":"22122","DOI":"10.1073\/pnas.1908353116","article-title":"KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis","volume":"116","author":"Rabara","year":"2019","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.bcp.2025.117291_b0110","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1158\/2159-8290.CD-20-0442","article-title":"An In Vivo Kras Allelic Series reveals Distinct Phenotypes of Common Oncogenic Variants","volume":"10","author":"Zafra","year":"2020","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bcp.2025.117291_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2017.07.008","article-title":"The Invading Anchor Cell Induces Lateral Membrane Constriction during Vulval Lumen Morphogenesis in C.elegans","volume":"42","author":"Yang","year":"2017","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117291_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2017.10.024","article-title":"Cell Invasion InVivo via Rapid Exocytosis of a Transient Lysosome-Derived Membrane Domain","volume":"43","author":"Naegeli","year":"2017","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2023.11.011","article-title":"A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS","volume":"31","author":"Duan","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2025.117291_b0130","doi-asserted-by":"crossref","unstructured":"Laurella LC, Mirakian NT, Garcia MN, Grasso DH, S\u00fclsen VP, Papademetrio DL. Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. Molecules (Basel, Switzerland). 2022;27(11).","DOI":"10.3390\/molecules27113492"},{"issue":"15","key":"10.1016\/j.bcp.2025.117291_b0135","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/0008-5472.CAN-20-3792","article-title":"Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition","volume":"81","author":"Yan","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0140","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1038\/s41598-017-08358-3","article-title":"Noninvasive Imaging of Ras activity by Monomolecular Biosensor based on Split-Luciferase Complementary Assay","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.117291_b0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/MCB.00884-12","article-title":"Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission","volume":"33","author":"van der Hoeven","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2025.117291_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105821","article-title":"Identification of harmine and \u03b2-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase a and for in vitro and in vivo anti-cancer studies","volume":"162","author":"Tarpley","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0155","article-title":"DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis","volume":"2","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2015","journal-title":"Mol. Cell. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117291_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14082034","article-title":"A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer","volume":"14","author":"Laham","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2025.117291_b0165","series-title":"bioRxiv : the Preprint Server for Biology","article-title":"Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A","author":"Brierley","year":"2023"},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112656","article-title":"DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral\/oropharyngeal squamous cell carcinoma","volume":"405","author":"Martin","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117291_b0175","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/gutjnl-2018-316128","article-title":"DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth","volume":"68","author":"Luna","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/abbi.1996.9771","article-title":"Inhibition of monoamine oxidase a by beta-carboline derivatives","volume":"337","author":"Kim","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"issue":"24","key":"10.1016\/j.bcp.2025.117291_b0185","article-title":"How to Separate Kinase Inhibition from Undesired Monoamine Oxidase a Inhibition-the Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine. Molecules (Basel","volume":"25","author":"Wurzlbauer","year":"2020","journal-title":"Switzerland)"},{"issue":"25","key":"10.1016\/j.bcp.2025.117291_b0190","doi-asserted-by":"crossref","first-page":"22222","DOI":"10.1074\/jbc.M202844200","article-title":"Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1","volume":"277","author":"Wong","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2025.117291_b0195","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00432-010-0835-6","article-title":"Targeting monoamine oxidase a in advanced prostate cancer","volume":"136","author":"Flamand","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117291_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132453","article-title":"Selectivity Profiling and Biological activity of Novel \u03b2-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors","volume":"10","author":"R\u00fcben","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117291_b0205","doi-asserted-by":"crossref","first-page":"11391","DOI":"10.1038\/ncomms11391","article-title":"Selective inhibition of the kinase DYRK1A by targeting its folding process","volume":"7","author":"Kii","year":"2016","journal-title":"Nat. Commun."},{"issue":"7873","key":"10.1016\/j.bcp.2025.117291_b0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12035-012-8326-1","article-title":"Dyrk1A, a serine\/threonine kinase, is involved in ERK and Akt activation in the brain of hyperhomocysteinemic mice","volume":"47","author":"Abekhoukh","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12943-017-0661-4","article-title":"C10ORF10\/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy","volume":"16","author":"Salcher","year":"2017","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.bcp.2025.117291_b0225","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1101\/gad.1573107","article-title":"Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation","volume":"21","author":"Kang","year":"2007","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0235","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/s41467-024-46811-w","article-title":"Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer","volume":"15","author":"Bulle","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117291_b0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tice.2018.10.002","article-title":"Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway","volume":"55","author":"Guo","year":"2018","journal-title":"Tissue Cell"},{"issue":"5","key":"10.1016\/j.bcp.2025.117291_b0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopsych.2021.01.012","article-title":"Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth factor Signaling","volume":"90","author":"Levy","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"19","key":"10.1016\/j.bcp.2025.117291_b0250","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1128\/MCB.00394-08","article-title":"Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A","volume":"28","author":"Aranda","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117291_b0255","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1091\/mbc.e04-12-1085","article-title":"DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1","volume":"16","author":"Kelly","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117291_b0260","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41419-019-1521-5","article-title":"Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bcp.2025.117291_b0265","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1111\/jcmm.14609","article-title":"DYRK1A inhibition suppresses STAT3\/EGFR\/Met signalling and sensitizes EGFR wild-type NSCLC cells to AZD9291","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117291_b0270","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1172\/JCI63623","article-title":"Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth","volume":"123","author":"Pozo","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bcp.2025.117291_b0275","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/j.apsb.2021.02.014","article-title":"Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators","volume":"11","author":"Qiu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.bcp.2025.117291_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.12.024","article-title":"G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling","volume":"184","author":"Prentzell","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2018.02.205","article-title":"Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy","volume":"498","author":"Geng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117291_b0290","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1038\/s41598-024-57196-7","article-title":"The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:33:14Z","timestamp":1761381194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0006295225005568"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117291","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS\/MAPK inhibition","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117291"}}